Market Research Logo

Anika Therapeutics Inc (ANIK) - Financial and Strategic SWOT Analysis Review

Anika Therapeutics Inc (ANIK) - Financial and Strategic SWOT Analysis Review

provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Anika Therapeutics Inc (Anika) develops, manufactures, and markets therapeutic products for tissue protection, repair and regeneration. It offers solutions for orthobiologics, dermal, ophthalmic, surgical and veterinary applications. Its major products include viscosupplementation and regenerative orthopedics products, advanced wound care devices, anti-adhesion gels, viscoelastic ophthalmic products, dental bone grafting adjuncts and joint dysfunction management fluids for horses. Its products are made from hyaluronic acid (HA) based on two technologies: HYAFF, which is a solid form of HA, and ACP gel, an autocross-linked polymer of HA. Anika has research and manufacturing facilities in Bedford, Massachusetts. The company offers its products through distributors in the Americas, Europe, the Middle East, and Asia. Anika is headquartered in Massachusetts, the US.

Anika Therapeutics Inc Key Recent Developments

Sep 05,2018: Anika appoints Dr. Cheryl Blanchard to its Board of Directors
Jul 25,2018: Anika reports second quarter 2018 financial results
May 02,2018: Anika Reports First Quarter 2018 Financial Results
Mar 05,2018: Anika Therapeutics Names Joseph Darling As CEO And Director
Feb 21,2018: Anika Announces Fourth Quarter and Full Year 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Anika Therapeutics Inc - Key Facts
Anika Therapeutics Inc - Key Employees
Anika Therapeutics Inc - Key Employee Biographies
Anika Therapeutics Inc - Major Products and Services
Anika Therapeutics Inc - History
Anika Therapeutics Inc - Company Statement
Anika Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Anika Therapeutics Inc - Business Description
Business Segment: Dermal
Overview
Performance
Business Segment: Orthobiologics
Overview
Performance
Business Segment: Other
Overview
Business Segment: Others
Performance
Business Segment: Surgical
Overview
Performance
Geographical Segment: Europe
Target Markets
Performance
Geographical Segment: Other
Target Markets
Performance
Geographical Segment: US
Performance
R&D Overview
Anika Therapeutics Inc - Corporate Strategy
Anika Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Anika Therapeutics Inc - Strengths
Anika Therapeutics Inc - Weaknesses
Anika Therapeutics Inc - Opportunities
Anika Therapeutics Inc - Threats
Anika Therapeutics Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Anika Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Anika Therapeutics Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018
Anika Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Sep 05, 2018: Anika appoints Dr. Cheryl Blanchard to its Board of Directors
Jul 25, 2018: Anika reports second quarter 2018 financial results
May 02, 2018: Anika Reports First Quarter 2018 Financial Results
Mar 05, 2018: Anika Therapeutics Names Joseph Darling As CEO And Director
Feb 21, 2018: Anika Announces Fourth Quarter and Full Year 2017 Financial Results
Oct 25, 2017: Anika Reports Third Quarter 2017 Financial Results
Oct 23, 2017: Anika Announces the Forthcoming Appointment of Thomas M. Finnerty as Chief Human Resources Officer
Aug 28, 2017: Anika Announces Appointment of Steven Chartier as Vice President of Regulatory and Clinical Affairs
Jul 27, 2017: Anika Announces Appointment of Joseph Darling as President
Jul 26, 2017: Anika Reports Strong Second Quarter 2017 Financial Results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Anika Therapeutics Inc, Key Facts
Anika Therapeutics Inc, Key Employees
Anika Therapeutics Inc, Key Employee Biographies
Anika Therapeutics Inc, Major Products and Services
Anika Therapeutics Inc, History
Anika Therapeutics Inc, Subsidiaries
Anika Therapeutics Inc, Key Competitors
Anika Therapeutics Inc, Ratios based on current share price
Anika Therapeutics Inc, Annual Ratios
Anika Therapeutics Inc, Annual Ratios (Cont...1)
Anika Therapeutics Inc, Annual Ratios (Cont...2)
Anika Therapeutics Inc, Interim Ratios
Anika Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Anika Therapeutics Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018
Anika Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Anika Therapeutics Inc, Performance Chart (2013 - 2017)
Anika Therapeutics Inc, Ratio Charts
Anika Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Anika Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report